Description
This option includes a provider evaluation for patients seeking compounded PT-141 (bremelanotide), followed by medication shipping when deemed appropriate. PT-141 may be used in men’s or women’s health settings and is often discussed for its potential role in sexual desire and response pathways. A licensed provider reviews the patient’s medical history, questionnaire responses, and relevant risk factors to determine whether treatment may be appropriate. If approved, medication is compounded and shipped directly to the patient. Treatment is not guaranteed and is subject to provider discretion.
There are no reviews yet.